(R,S)-Equol

(R,S)-Equol
Product Name (R,S)-Equol
CAS No.: 66036-38-2
Catalog No.: CFN70434
Molecular Formula: C15H14O3
Molecular Weight: 242.3 g/mol
Purity: >=98%
Type of Compound: Flavonoids
Physical Desc.: Powder
Targets: Estrogen receptor
Source: The seeds of Soy.
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Price: $150/5mg
S-equol and R/S-equol estrogen receptor β-selective phytoSERM treatments have potentiation of brain mitochondrial function.
Inquire / Order: manager@chemfaces.com
Technical Inquiries: service@chemfaces.com
Tel: +86-27-84237783
Fax: +86-27-84254680

Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • Separations2021, 8(6),80.
  • Research Square2020, doi: 10.21203.
  • BMC Complement Altern Med.2019, 19(1):325
  • Phytochem Anal.2024, pca.3319.
  • J Chromatogr B Analyt Technol Biomed Life Sci.2022, 1203:123307.
  • Phytomedicine.2019, 59:152785
  • Int J Mol Sci. 2014, 15(5):8443-57
  • Biomed Pharmacother.2024, 181:117658.
  • Anal Bioanal Chem.2016, 408(1):177-90.
  • Food Chem.2020, 327:126992.
  • Continentalic acid

    Catalog No: CFN90861
    CAS No: 19889-23-7
    Price: $168/20mg
    Vitexin

    Catalog No: CFN98601
    CAS No: 3681-93-4
    Price: $60/20mg
    Adenine

    Catalog No: CFN89041
    CAS No: 73-24-5
    Price: $30/20mg
    Isochlorogenic acid B

    Catalog No: CFN99119
    CAS No: 14534-61-3
    Price: $50/20mg
    Neohesperidin

    Catalog No: CFN99125
    CAS No: 13241-33-3
    Price: $40/20mg
    Brain Research, 2013, 1514:128-141.
    Potentiation of brain mitochondrial function by S-equol and R/S-equol estrogen receptor β-selective phytoSERM treatments.[Reference: WebLink]
    Previously we developed an estrogen receptor β-selective phytoestrogenic (phytoSERM) combination, which contains a mixture of genistein, daidzein, and racemic R/S-equol. The phytoSERM combination was found neuroprotective and non-feminizing both in vitro and in vivo. Further, it prevented or alleviated physical and neurological changes associated with human menopause and Alzheimer's disease.
    METHODS AND RESULTS:
    In the current study, we conducted translational analyses to compare the effects of racemic R/S-equol((R,S)-Equol)-containing with S-equol-containing phytoSERM therapeutic combinations on mitochondrial markers in rat hippocampal neuronal cultures and in a female mouse ovariectomy (OVX) model. Data revealed that both the S-equol and R/S-equol phytoSERM treatments regulated mitochondrial function, with S-equol phytoSERM combination eliciting greater response in mitochondrial potentiation. Both phytoSERM combination treatments increased expression of key proteins and enzymes involved in energy production, restored the OVX-induced decrease in activity of key bioenergetic enzymes, and reduced OVX-induced increase in lipid peroxidation. Comparative analyses on gene expression profile revealed similar regulation between S-equol phytoSERM and R/S-equol phytoSERM treatments with minimal differences. Both combinations regulated genes involved in essential bioenergetic pathways, including glucose metabolism and energy sensing, lipid metabolism, cholesterol trafficking, redox homeostasis and β-amyloid production and clearance. Further, no uterotrophic response was induced by either of the phytoSERM combinations.
    CONCLUSIONS:
    These findings indicate translational validity for development of an ER β selective S-equol phytoSERM combination as a nutraceutical to prevent menopause-associated symptoms and to promote brain metabolic activity.
    9-O-Acetyl-fargesol

    Catalog No: CFN95031
    CAS No: 449172-61-6
    Price: $413/5mg
    2-Cinnamoyl-1-galloylglucose

    Catalog No: CFN95098
    CAS No: 56994-83-3
    Price: $318/10mg
    Complanatoside C

    Catalog No: CFN95144
    CAS No: N/A
    Price: $318/5mg
    (R)-O-isobutyroyllomatin

    Catalog No: CFN95250
    CAS No: 440094-38-2
    Price: $318/5mg
    Dihydrophaseic acid 4'-O-beta-D-glucopyranoside

    Catalog No: CFN95393
    CAS No: 78914-56-4
    Price: $318/5mg
    Barbaloin-related compound B

    Catalog No: CFN95455
    CAS No: 473225-22-8
    Price: $318/5mg
    Rhamnocitrin 3-galactoside

    Catalog No: CFN95474
    CAS No: 99878-05-4
    Price: $318/10mg
    Massonianoside D

    Catalog No: CFN95500
    CAS No: 85115-04-4
    Price: $318/10mg
    Methyl lucidenate C

    Catalog No: CFN95541
    CAS No: N/A
    Price: $413/5mg
    Taxezopidine H

    Catalog No: CFN95562
    CAS No: 205440-23-9
    Price: $318/5mg